Concepedia

Publication | Open Access

KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study

97

Citations

20

References

2018

Year

Abstract

Changes in KRAS mutation status between preoperative and postoperative cfDNA may be a useful predictive biomarker for survival and treatment response.

References

YearCitations

Page 1